Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins
This study has been completed.
Study NCT00211029   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on September 13, 2005.   Last Updated on May 11, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Red-Cell Aplasia, Pure
More general conditions related to this trial
Anemia
Hematologic Diseases
Additional drug interventions recognized in this trial
Epoetin Alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services